We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Scotts Miracle-Gro (SMG) Q1 Earnings Top Estimates, Sales Lag
Read MoreHide Full Article
The Scotts Miracle-Gro Company (SMG - Free Report) reported a first-quarter fiscal 2024 (ended Dec 31, 2023) loss of $80.5 million or $1.42 per share compared with a loss of $64.7 million or $1.17 per share in the year-ago quarter.
Barring one-time items, the adjusted loss was $1.45 per share, wider than a loss of $1.02 a year ago. The figure was narrower than the Zacks Consensus Estimate of a loss of $1.62.
Net sales fell around 22% year over year to $410.4 million and also lagged the consensus mark of $423.3 million. Due to seasonality, the first quarter typically represents less than 15% of full-year sales.
The Scotts Miracle-Gro Company Price, Consensus and EPS Surprise
In the fiscal first quarter, net sales in the U.S. Consumer division were down 17% year over year to $306.7 million. It was lower than our estimate of $352.4 million.
Net sales in the Hawthorne segment plunged 39% year over year to $80.1 million in the reported quarter. The figure was higher than our estimate of $57.9 million. The downside reflects sustained pressure on the indoor and hydroponic industry and SMG’s move to restructure the business.
Net sales in the other segment fell 10% year over year to $23.6 million.
Balance Sheet
At the end of the quarter, the company had cash and cash equivalents of $10.4 million, down from $25.6 million in the year-ago quarter. Long-term debt was $2,969 million, down from $3,189.6 million in the year-ago quarter.
Outlook
The company reaffirmed its fiscal 2024 guidance, except for Hawthorne net sales, which are undergoing strategic changes. While the full impact on net sales is uncertain, Hawthorne aims for positive cash flow this year. The company's main objective is to strengthen its balance sheet, targeting $575 million adjusted EBITDA and $560 million free cash flow to achieve $1 billion in free cash flow over two years.
Price Performance
Shares of Scotts Miracle-Gro have lost 27.2% in the past year against a 38% decline of the industry.
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
Scotts Miracle-Gro currently carries a Zacks Rank #4 (Sell).
Cameco has a projected earnings growth rate of 188% for the current year. The Zacks Consensus Estimate for CCJ’s current-year earnings has been revised upward by 12.5% in the past 60 days. The stock is up around 68.5% in a year.
The consensus estimate for CRS’s current fiscal year earnings is pegged at $3.97, indicating a year-over-year surge of 248.3%. CRS beat the Zacks Consensus Estimate in all of the last four quarters, with the average earnings surprise being 14.3%. The company’s shares have rallied 28.1% in the past year.
The consensus estimate for CLF’s current fiscal year earnings is pegged at $2.27, indicating a year-over-year surge of 112%. The Zacks Consensus Estimate for CLF’s current-year earnings has been revised upward by 4.6% in the past 60 days. CLF beat the Zacks Consensus Estimate in all of the last four quarters, with the average earnings surprise being 24.7%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Scotts Miracle-Gro (SMG) Q1 Earnings Top Estimates, Sales Lag
The Scotts Miracle-Gro Company (SMG - Free Report) reported a first-quarter fiscal 2024 (ended Dec 31, 2023) loss of $80.5 million or $1.42 per share compared with a loss of $64.7 million or $1.17 per share in the year-ago quarter.
Barring one-time items, the adjusted loss was $1.45 per share, wider than a loss of $1.02 a year ago. The figure was narrower than the Zacks Consensus Estimate of a loss of $1.62.
Net sales fell around 22% year over year to $410.4 million and also lagged the consensus mark of $423.3 million. Due to seasonality, the first quarter typically represents less than 15% of full-year sales.
The Scotts Miracle-Gro Company Price, Consensus and EPS Surprise
The Scotts Miracle-Gro Company price-consensus-eps-surprise-chart | The Scotts Miracle-Gro Company Quote
Segment Details
In the fiscal first quarter, net sales in the U.S. Consumer division were down 17% year over year to $306.7 million. It was lower than our estimate of $352.4 million.
Net sales in the Hawthorne segment plunged 39% year over year to $80.1 million in the reported quarter. The figure was higher than our estimate of $57.9 million. The downside reflects sustained pressure on the indoor and hydroponic industry and SMG’s move to restructure the business.
Net sales in the other segment fell 10% year over year to $23.6 million.
Balance Sheet
At the end of the quarter, the company had cash and cash equivalents of $10.4 million, down from $25.6 million in the year-ago quarter. Long-term debt was $2,969 million, down from $3,189.6 million in the year-ago quarter.
Outlook
The company reaffirmed its fiscal 2024 guidance, except for Hawthorne net sales, which are undergoing strategic changes. While the full impact on net sales is uncertain, Hawthorne aims for positive cash flow this year. The company's main objective is to strengthen its balance sheet, targeting $575 million adjusted EBITDA and $560 million free cash flow to achieve $1 billion in free cash flow over two years.
Price Performance
Shares of Scotts Miracle-Gro have lost 27.2% in the past year against a 38% decline of the industry.
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
Scotts Miracle-Gro currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the Basic Materials space are Cameco Corporation (CCJ - Free Report) and Carpenter Technology Corporation (CRS - Free Report) , both sporting a Zacks Rank #1 (Strong Buy), and Cleveland-Cliffs Inc. (CLF - Free Report) , carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Cameco has a projected earnings growth rate of 188% for the current year. The Zacks Consensus Estimate for CCJ’s current-year earnings has been revised upward by 12.5% in the past 60 days. The stock is up around 68.5% in a year.
The consensus estimate for CRS’s current fiscal year earnings is pegged at $3.97, indicating a year-over-year surge of 248.3%. CRS beat the Zacks Consensus Estimate in all of the last four quarters, with the average earnings surprise being 14.3%. The company’s shares have rallied 28.1% in the past year.
The consensus estimate for CLF’s current fiscal year earnings is pegged at $2.27, indicating a year-over-year surge of 112%. The Zacks Consensus Estimate for CLF’s current-year earnings has been revised upward by 4.6% in the past 60 days. CLF beat the Zacks Consensus Estimate in all of the last four quarters, with the average earnings surprise being 24.7%.